Clinical Trials Logo

Clinical Trial Summary

Opioid overdoses have in the last decade counted for about 230 untimely deaths annually in Norway. The government is currently implementing a strategy for combating this epidemic. Among the actions promoted in this strategy is the distribution of naloxone for intranasal administration. Such administration of naloxone is currently being implemented and tried out around the world, but very little has been done to pharmacologically study this new route of administration of this well known drug, and only 3 open label randomized controlled trials (RCTs) have been conducted. A recent guideline from the WHO on community management of opioid overdoses is a comprehensive review of many of the aspects the investigators cover in our research.

Regarding both dosage, routes of administration of naloxone and care of these patients in the pre hospital setting. The WHO calls for nasal formulations with a higher concentration, as well as focuses on the current wide spread off label use of nasal naloxone as a problem and identifies several research questions of critical importance and very low evidence.The current study, together with our research group's previous and future studies, aims to provide data for the development of a medicinal product with marketing authorisation for use in pre-hospital overdoses. This to contribute to public health measures for opioid users and those around them.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02598856
Study type Interventional
Source Norwegian University of Science and Technology
Contact
Status Completed
Phase Phase 1
Start date March 2016
Completion date December 2016

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04070521 - EEG Monitoring in the Emergency Department
Completed NCT04372238 - The Rhode Island Prescription and Illicit Drug Study N/A
Withdrawn NCT04391192 - Virtual Overdose Response N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Not yet recruiting NCT01912573 - Nasal Naloxone for Narcotic Overdose Phase 4
Completed NCT04091659 - Use of Virtual Reality for Overdose Management Educational Trainings N/A
Recruiting NCT05517668 - Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose Phase 2
Completed NCT02152397 - Safety and Health Intervention Project N/A
Completed NCT02572089 - Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers Phase 1
Active, not recruiting NCT05096429 - Preventing Overdose Using Information and Data From the Environment N/A
Recruiting NCT03845699 - Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
Completed NCT03840018 - Effectiveness of a Postal Intervention to Improve the Use of PPI N/A
Completed NCT03087149 - Monitored vs Standard Supplementation of Vitamin D in Preterm Infants N/A
Recruiting NCT05657106 - Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk N/A
Completed NCT02158117 - Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use Phase 1
Recruiting NCT05146336 - CytOSorb TreatMent Of Critically Ill PatientS Registry
Not yet recruiting NCT02733822 - Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study Phase 1
Not yet recruiting NCT06327061 - Social Network Overdose Prevention and Education Intervention N/A
Active, not recruiting NCT05308303 - AI to Improve Data From Danish Cardiac Arrest Registry